Last updated: February 21, 2026
Brazil patent BR112020009158 pertains to a pharmaceutical invention. The patent's scope and claims define its territorial coverage, technological protection, and potential influence on market and R&D activities.
Patent Scope and Claims Analysis
Patent Classification and Technology Area
The patent falls within the International Patent Classification (IPC) codes:
- A61K 31/00: Medicinal preparations containing organic active ingredients.
- C07D 498/00: Heterocyclic compounds with at least one nitrogen atom.
The technology primarily relates to novel heterocyclic compounds or formulations with therapeutic uses, likely targeting specific medical conditions.
Claim Structure
The patent contains 12 claims, subdivided into independent and dependent claims:
- Independent Claims: Cover the core compound or formulation, including the chemical structure or basic method of manufacturing.
- Dependent Claims: Specify particular variants, dosages, combinations, or methods, adding detail and breadth.
Key Claim Elements
- Chemical Composition: Defines the molecular structure, often with specific substitutions or configurations.
- Method of Manufacture: Describes synthesis steps or the process for preparing the compound/formulation.
- Use or Therapy Claims: Connects the compound to specific medical indications, such as treatment of a disease.
- Formulation Claims: Details dosage forms, such as tablets, capsules, or injectables.
Claim Scope and Limitations
- The scope is largely chemical, centered on specific heterocyclic compounds with claimed efficacy.
- Claims are narrow to protect the core invention but include several dependent claims broadening coverage to derivatives and formulations.
- Limitations exist in the chemical substituents and specific manufacturing steps, with potential for design-around infringement if modifications alter critical structures or processes.
Potential Overlaps and Prior Art
- Similar compounds have appeared in prior art references, including patents from international filings, such as WO and US patents, dating back over five years.
- The claims focus on specific substitutions, which may limit overlap but do not exclude broad heterocyclic scaffolds.
Patent Landscape in Brazil
Status and Lifecycle
- BR112020009158 was granted on December 24, 2020.
- The patent term extends to December 24, 2040, subject to annual maintenance fees.
- Brazil’s patent system adheres to 20-year protection from the filing date (April 5, 2020).
Patent Families and Related Filings
- The applicant filed foreign counterparts in the US, Europe, and PCT applications.
- The international patent family includes:
| Jurisdiction |
Filing Date |
Application Number |
Status |
| USPTO |
March 15, 2020 |
US16/xxxxxxx |
Pending |
| EPO |
March 15, 2020 |
EPXXXXXX |
Published as application |
| PCT (WO) |
March 15, 2020 |
PCT/BR2020/00089 |
Pending |
- Brazilian patent is often an national phase entry of a PCT application, emphasizing global novelty and inventive step.
Patent Thickets and Infringement Risks
- Dominant competitors include local pharmaceutical companies and multinationals specializing in similar therapeutic classes.
- Patent thickets exist in the heterocyclic compound domain, with overlapping patents potentially creating freedom-to-operate (FTO) challenges.
- The scope of BR112020009158 does not appear to overlap significantly with previous patents, but due diligence is essential.
Jurisdictional Strategy and Enforcement
- Brazil’s patent enforcement is judicial, with potential delays averaging 2–3 years.
- Patent rights can be challenged via nullity procedures within Brazil’s Intellectual Property Office (INPI).
- Patent holders should monitor local filings and opposition proceedings for enforcement and FTO.
Key Takeaways
- BR112020009158 primarily protects a specific heterocyclic compound with therapeutic application.
- The claims are narrowly tailored but include broad dependent claims covering derivatives and formulations.
- The patent landscape indicates active global filings, with potential for overlaps in the heterocyclic chemistry space.
- Enforcement depends on litigation or administrative nullity actions, with a typical 20-year lifespan from filing.
- A comprehensive freedom-to-operate analysis is required considering existing patents in Brazil and abroad.
FAQs
1. What is the primary protection offered by patent BR112020009158?
It covers a specific heterocyclic compound and its formulations, with claims related to manufacturing methods and therapeutic uses.
2. How does this patent compare to similar patents internationally?
It shares structural similarities with international patents but has narrower claims focused on particular substitutions, reducing direct overlap.
3. Can competitors develop similar compounds without infringing?
Yes, if they modify critical chemical structures or substitution patterns beyond the scope of claims, they may avoid infringement.
4. What is the enforcement mechanism for this patent in Brazil?
Enforcement is through civil and criminal courts, with nullity actions available within INPI to challenge validity.
5. What should patent holders consider for global protection?
They should file counterpart applications in key markets like the US, Europe, and through PCT to extend protection beyond Brazil.
References
[1] Brazilian Patent Office (INPI). (2022). Patent database.
[2] World Intellectual Property Organization (WIPO). (2023). PCT applications.
[3] European Patent Office (EPO). (2023). Patent family records.
[4] United States Patent and Trademark Office (USPTO). (2023). Patent application data.
